Austco Healthcare Ltd · ASX:AHC
Austco Healthcare — H1 2019 Earnings Presentation
12 slides from Austco Healthcare's earnings presentation, Feb 27, 2019
Slide 1: 1HFY19 Results Presentation
1HFY19 RESULTS PRESENTATION 27 FEBRUARY 2019 1
Slide 2: 1HFY19 Summary
1HFY19 SUMMARY • Revenue of $14.97 million exceeds November guidance Financial • Reported loss of $0.47 million, normalised profit of $0.26 million excluding one-off items Performance • Cash balance as at 31 December of $2.01 million • Debt reduced by 37% to $0.41 million • Innovative new products r
Slide 3: 1HFY19 Financial Snapshot
1HFY19 FINANCIAL SNAPSHOT Revenue Margin NPAT $14.97m $6.66m ($0.47m) Normalised $6.84m Normalised $0.26m $0.73m or Consistent with Normalised 5.1% on pcp ($0.18m) or pcp (41%) on pcp Cashflow from Net Cash Operations $1.60m $0.68m ($0.05m) from $0.22m or 30 June 49% on pcp * pcp: prior comparative
Slide 4: Revenue
REVENUE SALES REVENUE (A$000S) Continued growth in sales revenue over pcp and November ‘18 guidance: • $1.44m (10.7%) above November ‘18 14,972 guidance 14,242 • $0.73m (5.1%) increase over 1HFY18 13,530 13,054 • 7% CAGR from 1HFY17 • Aust/NZ, Asia and Europe all reported revenue increases • recurri
Slide 5: Gross Profit & Margin
GROSS PROFIT & MARGIN GROSS PROFIT MARGIN Gross margin down to 44.5% compared (A$000S) to 48% pcp: • negatively impacted by rising costs of raw 6,836 6,662 6,843 materials resulting from US tariff imposts 5,990 48.0% 44.5% 45.7% on Chinese goods 45.9% • total CoGS up by 12.6% as result of increased
Slide 6: Overhead Expenses
OVERHEAD EXPENSES OVERHEAD EXPENSES Overhead increased by $0.71m to $7.11m in (A$000S) 1H19: • increase driven by large one off costs of 8,256 $0.54m related to management restructuring 544 • normalised overhead increased 2.6% over 6,567 6,399 1H18 to $6.57m • the business remains committed to R&D,
Slide 7: Cash & Debt
CASH & DEBT Cashflow from operations continue Net cash was largely unchanged over to improve: the period with a minor decrease of $0.05m from $1.65m to $1.60m: • cashflow from operations of $0.68 million increased from $0.45 million in • debt was reduced by $0.24m the pcp • cash was reduced by $0.30
Slide 8: Product Update
PRODUCT UPDATE Pulse Mobile Web Services Enhanced Reporting and Analytics • One of our most popular • Open API for alarms software products • RTLS complete • True enterprise reporting • Released in FY18 • Additional integrations • Added functionality, expanded • Native smart phone app are a longer t
Slide 9: Progress on Strategy
PROGRESS ON STRATEGY Strategic Objective Status Focus on high quality new products that differentiate ‣ Released new products including Azure from its competitors Pulse Workflow Improve manufacturing efficiencies to drive further ‣ Material requirements planning cost reductions (MRP) system deployed
Slide 10: Outlook
OUTLOOK External Internal • Increasing shift towards open software • Order book remains significantly packages to accompany hardware higher than forecast despite supply constraint issues • Procurement challenges will continue to be dominated by trade issues • Strong demand across all geographic betw
Slide 11: Disclaimer
DISCLAIMER This Publication does not constitute an offer, invitation or recommendation for the sale or purchase of any securities in any jurisdiction. References to, and the explanation of, legislation and regulatory issues in this Publication are indicative only and should not be relied on. They do
Slide 12: Azure Healthcare Limited
\a ry AZURE HEALTHCARE LIMITED